CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 50 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $145,000 | +5.1% | 9,861 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $138,000 | -17.9% | 9,861 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $168,000 | -6.1% | 9,861 | -43.2% | 0.00% | 0.0% |
| Q4 2016 | $179,000 | -51.5% | 17,367 | -52.4% | 0.00% | -50.0% |
| Q3 2016 | $369,000 | -12.1% | 36,450 | -2.6% | 0.00% | 0.0% |
| Q2 2016 | $420,000 | -17.2% | 37,420 | +0.9% | 0.00% | 0.0% |
| Q1 2016 | $507,000 | +162.7% | 37,098 | +263.8% | 0.00% | +100.0% |
| Q4 2015 | $193,000 | +3.8% | 10,198 | +3.2% | 0.00% | 0.0% |
| Q3 2015 | $186,000 | +26.5% | 9,885 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $147,000 | -25.8% | 9,885 | -33.0% | 0.00% | 0.0% |
| Q1 2014 | $198,000 | – | 14,746 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,253,000 | $7,097,000 | 0.26% |
| INGALLS & SNYDER LLC | 1,358,573 | $4,280,000 | 0.19% |
| RA Capital Management | 3,033,603 | $9,556,000 | 0.17% |
| Kensington Investment Counsel, LLC | 85,483 | $269,000 | 0.16% |
| Perceptive Advisors | 4,301,282 | $13,548,000 | 0.10% |
| NewEdge Wealth, LLC | 381,326 | $1,201,000 | 0.05% |
| Black Diamond Financial, LLC | 46,000 | $145,000 | 0.05% |
| Birchview Capital, LP | 20,000 | $63,000 | 0.04% |
| XTX Topco Ltd | 14,305 | $45,000 | 0.02% |
| Alyeska Investment Group, L.P. | 548,090 | $1,726,000 | 0.02% |